Thomas Patrick Kelly insider trades

Open-market stock purchases and sales by Thomas Patrick Kelly, Chief Financial Officer at Xenon Pharmaceuticals Inc, from SEC Form 4 filings since Oct 2, 2017.

Recent trades

DateStockTradeValue
Oct 15, 2025XENE Xenon Pharmaceuticals IncBought (not open market)—
Oct 15, 2025XENE Xenon Pharmaceuticals IncBought (not open market)—

Companies traded

  • XENE Xenon Pharmaceuticals Inc: other filings, last Oct 15, 2025
  • DCPH Deciphera Pharmaceuticals, Inc: 39 sales, last Feb 16, 2024

Get free alerts when Thomas Patrick Kelly files a new trade →